- $895.98m
- $2.44bn
- $2.19bn
- 65
- 88
- 88
- 94
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,009 | 1,791 | 2,022 | 2,238 | 2,192 |
Cost of Revenue | |||||
Gross Profit | 1,196 | 1,060 | 1,138 | 1,206 | 1,163 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,197 | 1,750 | 1,880 | 2,069 | 2,031 |
Operating Profit | -188 | 40.7 | 142 | 169 | 161 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -216 | 26.8 | 93.8 | 84.4 | 39.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -224 | 5.33 | 62.8 | 65.5 | 26.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -224 | 5.24 | 62.6 | 65.4 | 26.1 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -224 | 5.19 | 62.6 | 65.3 | 26.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.12 | 3.01 | 2.72 | 2.28 | 1.5 |
Dividends per Share |